Abstract P80: Initial and 12 Month Outcomes After Percutaneous Coronary Intervention in Australian Private Hospitals; Results From a National Multi-Centre Registry
Background: Several large multi-centre registries have evaluated outcomes after percutaneous coronary intervention (PCI) in the USA, however there is little data regarding the outcomes of patients in Australian Private hospitals. The aim of this study was to report the initial results of a new multi-centre registry. Methods: We prospectively enrolled consecutive patients (n=951) undergoing PCI to 1179 lesions at 6 Australian private hospitals from November 2008 to February 2010. Baseline patient/procedural data and in-hospital and 30 day and 12 month outcomes were recorded on case report forms. Data is stored electronically in the department of Epidemiology at Monash University. Results: The mean age ± SD was 67 ± 12 years. Females comprised 29.7 % (282/951), diabetics 26.6% (252/951), 33% (313/951) were obese (BMI>30) and 19% (181/951) had acute coronary syndromes. At least one DES was used in 64% of PCI (755/1179). In patients not taking Warfarin, 99.4% were taking aspirin and 98.8% clopidogrel at discharge. At 12 months, 10% (96/951) had undergone further revascularisation by PCI or CABG however only 1.1% (11/951) required target vessel revascularisation. Conclusion: A prospective, multicentre registry providing outcomes after PCI in private hospitals is feasible. Australian practice and in-hospital outcomes after PCI are consistent with those reported in American/European registries. One year follow up data will be presented. Outcomes at discharge (%) PCI Success 99.4 Death- Overall - Patients without pre-procedural shock 0.0 0.0 Myocardial infarction 2.4 Stroke 0.0 Urgent/ Early Target vessel revascularisation 0.6